Eric Lachacz is the Director of Integrated Bioanalysis at AstraZeneca, where they develop novel bioanalytical platforms to support an expanding portfolio of new modality drugs in a GxP environment. Previously, as an Associate Director and group lead, Eric designed assays for clinical trials, focusing on overcoming challenges associated with PK/PD bioanalysis. Eric's extensive experience includes developing methodologies for target identification in cancer research during their graduate and postdoctoral studies at the University of Michigan. They earned a PhD in Medicinal Chemistry from the University of Michigan, following a Bachelor of Science in Chemistry with a concentration in Biochemistry from St. John Fisher College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices